JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Michael E. Halkos
John D. Puskas
Omar M. Lattouf
Faraz Kerendi
Howard K. Song
Robert A. Guyton
Vinod H. Thourani
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Halkos, M. E.
Right arrow Articles by Thourani, V. H.
PubMed
Right arrow Articles by Halkos, M. E.
Right arrow Articles by Thourani, V. H.
Related Collections
Right arrow Cardiac - other
Right arrow Coronary disease

J Thorac Cardiovasc Surg 2008;136:631-640
© 2008 The American Association for Thoracic Surgery

Surgery for Acquired Cardiovascular Disease

Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery

Michael E. Halkos, MDa, John D. Puskas, MDb, Omar M. Lattouf, MD, PhDa, Patrick Kilgo, MScb, Faraz Kerendi, MDa, Howard K. Song, MD, PhDc, Robert A. Guyton, MDa, Vinod H. Thourani, MDa,*

a Clinical Research Unit, Division of Cardiothoracic Surgery, Emory University School of Medicine, Atlanta, Georgia
b Department of Biostatistics, Rollins School of Public Health, Emory University School of Medicine, Atlanta, Georgia
c Division of Cardiothoracic Surgery, Oregon Health and Science University, Portland, Oregon

Received for publication May 8, 2007; revisions received January 12, 2008; accepted for publication February 7, 2008.

* Address for reprints: Vinod H. Thourani, MD, 550 Peachtree Street, Crawford Long Hospital, 6th Floor, Medical Office Tower, Cardiothoracic Surgery, Atlanta, GA 30308. (Email: vinod.thourani{at}emoryhealthcare.org).

Objective: Diabetes mellitus has been associated with an increased risk of adverse outcomes after coronary artery bypass grafting. Hemoglobin A1c is a reliable measure of long-term glucose control. It is unknown whether adequacy of diabetic control, measured by hemoglobin A1c, is a predictor of adverse outcomes after coronary artery bypass grafting.

Methods: Of 3555 consecutive patients who underwent primary, elective coronary artery bypass grafting at a single academic center from April 1, 2002, to June 30, 2006, 3089 (86.9%) had preoperative hemoglobin A1c levels obtained and entered prospectively into a computerized database. All patients were treated with a perioperative intravenous insulin protocol. A multivariable logistic regression model was used to determine whether hemoglobin A1c, as a continuous variable, was associated with in-hospital mortality, renal failure, cerebrovascular accident, myocardial infarction, and deep sternal wound infection after coronary artery bypass grafting. Receiver operating characteristic curve analysis identified the hemoglobin A1c value that maximally discriminated outcome dichotomies.

Results: In-hospital mortality for all patients was 1.0% (31/3089). An elevated hemoglobin A1c level predicted in-hospital mortality after coronary artery bypass grafting (odds ratio 1.40 per unit increase, P = .019). Receiver operating characteristic curve analysis revealed that hemoglobin A1c greater than 8.6% was associated with a 4-fold increase in mortality. For each unit increase in hemoglobin A1c, there was a significantly increased risk of myocardial infarction and deep sternal wound infection. By using receiver operating characteristic value thresholds, renal failure (threshold 6.7, odds ratio 2.1), cerebrovascular accident (threshold 7.6, odds ratio 2.24), and deep sternal wound infection (threshold 7.8, odds ratio 5.29) occurred more commonly in patients with elevated hemoglobin A1c.

Conclusion: Elevated hemoglobin A1c level was strongly associated with adverse events after coronary artery bypass grafting. Preoperative hemoglobin A1c testing may allow for more accurate risk stratification in patients undergoing coronary artery bypass grafting.

Abbreviations and Acronyms AUROC = area under the receiver operating characteristic; CABG = coronary artery bypass grafting; CPB = cardiopulmonary bypass; CVA = cerebrovascular accident; DSWI = deep sternal wound infection; HbA1C = hemoglobin A1c; LOS = length of stay; MI = myocardial infarction; OR = odds ratio




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
M. E. Halkos, O. M. Lattouf, J. D. Puskas, P. Kilgo, W. A. Cooper, C. D. Morris, R. A. Guyton, and V. H. Thourani
Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery.
Ann. Thorac. Surg., November 1, 2008; 86(5): 1431 - 1437.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The American Association for Thoracic Surgery.